Trials / Completed
CompletedNCT00362011
Effect of Chia Seeds (Salvia Hispanica L.) on Glucose Control in Patients With Type 2 Diabetes
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Unity Health Toronto · Academic / Other
- Sex
- All
- Age
- 35 Years – 75 Years
- Healthy volunteers
- —
Summary
The purpose of this study is to determine whether the addition of Salvia hispanica L. Alba (Salba) to the conventional treatment for diabetes is associated with improvement in major and emerging cardiovascular risk factors in people with type 2 diabetes.
Detailed description
Cohort studies have linked consumption of whole grain with a reduction in the risk of developing diabetes and heart disease. Grain of the plant Salvia hispanica alba (Salba) contain a high concentration of ω-3 fatty acids in addition to being a rich source of vegetable protein, fiber, calcium and antioxidants which have cardiovascular protective effect. To address the paucity of randomized, well-controlled clinical studies supporting the long-term cardioprotective benefits of whole grain we investigated the effects of a novel grain Salba in type 2 diabetes. Comparison(s): Participants on a conventional diabetes diet (50% carbohydrate, 20% protein, 30% fat) receive either addition of Salba or matched control supplement for 12 weeks separated by a 4-week washout period.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Salba diet |
Timeline
- Start date
- 2001-03-01
- First posted
- 2006-08-09
- Last updated
- 2006-08-09
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT00362011. Inclusion in this directory is not an endorsement.